CN104087683A - 微卫星不稳定性多重检测体系及试剂盒 - Google Patents
微卫星不稳定性多重检测体系及试剂盒 Download PDFInfo
- Publication number
- CN104087683A CN104087683A CN201410377852.2A CN201410377852A CN104087683A CN 104087683 A CN104087683 A CN 104087683A CN 201410377852 A CN201410377852 A CN 201410377852A CN 104087683 A CN104087683 A CN 104087683A
- Authority
- CN
- China
- Prior art keywords
- primer
- final concentration
- bat
- flu
- detection system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 47
- 208000032818 Microsatellite Instability Diseases 0.000 title claims abstract description 34
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 35
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 108091092878 Microsatellite Proteins 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 5
- 239000002773 nucleotide Substances 0.000 claims description 28
- 125000003729 nucleotide group Chemical group 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 18
- 238000013016 damping Methods 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 13
- 239000013642 negative control Substances 0.000 claims description 8
- 239000013641 positive control Substances 0.000 claims description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- 239000013612 plasmid Substances 0.000 claims description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 4
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 4
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 4
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 4
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 4
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 15
- 230000007547 defect Effects 0.000 abstract description 2
- 238000003752 polymerase chain reaction Methods 0.000 abstract 2
- 238000001215 fluorescent labelling Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 45
- 238000012360 testing method Methods 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 18
- 239000012634 fragment Substances 0.000 description 16
- 206010028980 Neoplasm Diseases 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000011259 mixed solution Substances 0.000 description 10
- 230000003321 amplification Effects 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 206010009944 Colon cancer Diseases 0.000 description 8
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 208000017095 Hereditary nonpolyposis colon cancer Diseases 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000007403 mPCR Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000005251 capillar electrophoresis Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 208000008051 Hereditary Nonpolyposis Colorectal Neoplasms Diseases 0.000 description 2
- 201000005027 Lynch syndrome Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000033607 mismatch repair Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410377852.2A CN104087683B (zh) | 2014-08-01 | 2014-08-01 | 微卫星不稳定性多重检测体系及试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410377852.2A CN104087683B (zh) | 2014-08-01 | 2014-08-01 | 微卫星不稳定性多重检测体系及试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104087683A true CN104087683A (zh) | 2014-10-08 |
CN104087683B CN104087683B (zh) | 2016-06-15 |
Family
ID=51635441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410377852.2A Active CN104087683B (zh) | 2014-08-01 | 2014-08-01 | 微卫星不稳定性多重检测体系及试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104087683B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107526944A (zh) * | 2017-09-06 | 2017-12-29 | 南京世和基因生物技术有限公司 | 一种微卫星不稳定性的测序数据分析方法、装置及计算机可读介质 |
CN107937396A (zh) * | 2017-12-29 | 2018-04-20 | 北京莲和医学检验所有限公司 | 引物组、试剂盒以及同时检测单态性单核苷酸重复位点微卫星不稳定的方法 |
CN108441558A (zh) * | 2018-02-12 | 2018-08-24 | 杭州和壹基因科技有限公司 | 肿瘤细胞微卫星不稳定性的复合扩增体系及检测试剂盒 |
CN108676891A (zh) * | 2018-07-12 | 2018-10-19 | 吉林大学 | 一种直肠腺癌易感性预测试剂盒及系统 |
CN109477244A (zh) * | 2015-12-08 | 2019-03-15 | Bcd创新公司 | 在配对的颊粘膜拭子和尿液样本中使用微卫星分析进行膀胱癌检测 |
CN109593847A (zh) * | 2017-09-29 | 2019-04-09 | 傅新晖 | 检测微卫星nr24位点稳定性的引物对、试剂盒及方法 |
CN110305958A (zh) * | 2018-11-23 | 2019-10-08 | 郑州海普生物医药科技有限公司 | 一种msi检测方法 |
CN110621784A (zh) * | 2017-03-24 | 2019-12-27 | 海阳生物材料有限公司 | 使用双功能pna探针进行熔解曲线分析的方法、以及使用所述方法诊断微卫星不稳定性的方法和诊断微卫星不稳定性的试剂盒 |
CN110699455A (zh) * | 2019-10-29 | 2020-01-17 | 苏州绘真医学检验有限公司 | 人循环肿瘤细胞msi检测引物组、试剂盒及检测方法 |
CN110621784B (zh) * | 2017-03-24 | 2024-06-11 | 海阳生物材料有限公司 | 使用双功能pna探针诊断微卫星不稳定性的方法和诊断微卫星不稳定性的试剂盒 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021092299A1 (en) * | 2019-11-08 | 2021-05-14 | Life Technologies Corporation | Systems and assays for assessing microsatellite instability |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072822A2 (en) * | 2002-02-28 | 2003-09-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Mononucleotide repeats microsatellite markers for detecting microsatellite instability. |
CN102230004A (zh) * | 2011-06-08 | 2011-11-02 | 北京阅微基因技术有限公司 | 肿瘤细胞微卫星不稳定状态的复合扩增体系及检测试剂盒 |
CN103555843A (zh) * | 2013-11-05 | 2014-02-05 | 上海赛安生物医药科技有限公司 | 结直肠癌微卫星不稳定性扩增体系及其检测试剂盒 |
CN103805707A (zh) * | 2014-02-19 | 2014-05-21 | 上海赛安生物医药科技有限公司 | 检测染色体缺失的复合扩增体系及其检测试剂盒 |
-
2014
- 2014-08-01 CN CN201410377852.2A patent/CN104087683B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072822A2 (en) * | 2002-02-28 | 2003-09-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Mononucleotide repeats microsatellite markers for detecting microsatellite instability. |
CN102230004A (zh) * | 2011-06-08 | 2011-11-02 | 北京阅微基因技术有限公司 | 肿瘤细胞微卫星不稳定状态的复合扩增体系及检测试剂盒 |
CN103555843A (zh) * | 2013-11-05 | 2014-02-05 | 上海赛安生物医药科技有限公司 | 结直肠癌微卫星不稳定性扩增体系及其检测试剂盒 |
CN103805707A (zh) * | 2014-02-19 | 2014-05-21 | 上海赛安生物医药科技有限公司 | 检测染色体缺失的复合扩增体系及其检测试剂盒 |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109477244A (zh) * | 2015-12-08 | 2019-03-15 | Bcd创新公司 | 在配对的颊粘膜拭子和尿液样本中使用微卫星分析进行膀胱癌检测 |
CN110621784A (zh) * | 2017-03-24 | 2019-12-27 | 海阳生物材料有限公司 | 使用双功能pna探针进行熔解曲线分析的方法、以及使用所述方法诊断微卫星不稳定性的方法和诊断微卫星不稳定性的试剂盒 |
CN110621784B (zh) * | 2017-03-24 | 2024-06-11 | 海阳生物材料有限公司 | 使用双功能pna探针诊断微卫星不稳定性的方法和诊断微卫星不稳定性的试剂盒 |
CN107526944B (zh) * | 2017-09-06 | 2018-08-24 | 南京世和基因生物技术有限公司 | 一种微卫星不稳定性的测序数据分析方法、装置及计算机可读介质 |
CN107526944A (zh) * | 2017-09-06 | 2017-12-29 | 南京世和基因生物技术有限公司 | 一种微卫星不稳定性的测序数据分析方法、装置及计算机可读介质 |
US10998084B2 (en) | 2017-09-06 | 2021-05-04 | Nanjing Shihe Gene Biotechnology Co., Ltd. | Sequencing data analysis method, device and computer-readable medium for microsatellite instability |
CN109593847A (zh) * | 2017-09-29 | 2019-04-09 | 傅新晖 | 检测微卫星nr24位点稳定性的引物对、试剂盒及方法 |
CN107937396A (zh) * | 2017-12-29 | 2018-04-20 | 北京莲和医学检验所有限公司 | 引物组、试剂盒以及同时检测单态性单核苷酸重复位点微卫星不稳定的方法 |
CN108441558A (zh) * | 2018-02-12 | 2018-08-24 | 杭州和壹基因科技有限公司 | 肿瘤细胞微卫星不稳定性的复合扩增体系及检测试剂盒 |
CN108676891B (zh) * | 2018-07-12 | 2022-02-01 | 吉林大学 | 一种直肠腺癌易感性预测试剂盒及系统 |
CN108676891A (zh) * | 2018-07-12 | 2018-10-19 | 吉林大学 | 一种直肠腺癌易感性预测试剂盒及系统 |
CN110305958A (zh) * | 2018-11-23 | 2019-10-08 | 郑州海普生物医药科技有限公司 | 一种msi检测方法 |
CN110699455A (zh) * | 2019-10-29 | 2020-01-17 | 苏州绘真医学检验有限公司 | 人循环肿瘤细胞msi检测引物组、试剂盒及检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104087683B (zh) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104087683A (zh) | 微卫星不稳定性多重检测体系及试剂盒 | |
CN103555843B (zh) | 结直肠癌微卫星不稳定性扩增体系及其检测试剂盒 | |
CN104805208B (zh) | 用于检测人类kras基因7种热点突变的引物探针组合物、试剂盒及检测方法 | |
CN104099425A (zh) | 一种用于检测B-raf基因突变的试剂盒 | |
CN103074436B (zh) | 一种指导5-氟尿嘧啶用药的多重基因检测试剂盒及其检测方法 | |
CN103074434A (zh) | 一种cyp2c19基因多态性检测试剂盒及其检测方法 | |
CN106148552A (zh) | 人类y染色体30个str基因座的荧光标记复合扩增试剂盒及其应用 | |
CN104593520B (zh) | 一种肺癌miRNA检测试剂盒及其miRNA的应用 | |
CN104651488B (zh) | 检测染色体非整倍体数目异常的扩增组合物及快速检测试剂盒 | |
EP2218794A1 (en) | Detection of instability in regions of genomic DNA containing simple tandem repeats | |
CN104120080A (zh) | 一种α-珠蛋白基因突变检测试剂盒及其制备方法与应用 | |
CN106222244A (zh) | 核苷酸序列、通用反向引物、通用反转录引物、引物设计方法及miRNA检测方法 | |
Sigalotti et al. | Quantitative methylation-specific PCR: a simple method for studying epigenetic modifications of cell-free DNA | |
EP2607495A1 (en) | Method for detection of KRAS mutations | |
CN105647923B (zh) | 与肝癌预后相关的血清miRNA标志物及其检测试剂盒的应用 | |
CN106520929A (zh) | 非小细胞肺癌检测引物探针及其试剂盒 | |
CN103103259A (zh) | 确定核酸样本的两个预定位点是否具有已知突变的方法、试剂盒以及引物 | |
CN103571959B (zh) | 用于检测基因位点突变的引物、探针、试剂盒 | |
CN105506101B (zh) | As-pcr引物设计方法、基因多态性检测方法及试剂盒 | |
CN106282387A (zh) | 胃癌检测引物探针及其试剂盒 | |
CN108359713B (zh) | 一种基因多态性检测探针的筛选方法 | |
CN103074437B (zh) | 一种指导铂类药物用药的多重基因检测试剂盒及其检测方法 | |
Stverakova et al. | Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer | |
CN101183067A (zh) | 用于个人识别的13个snp位点多色荧光复合扩增试剂盒 | |
Poumpouridou et al. | Development and validation of molecular methodologies to assess PALB2 expression in sporadic breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201022 Address after: 274000 No. 2888 Zhonghua West Road, hi tech Zone, Shandong, Heze Patentee after: GUOJIUTANG SHANDONG DONKEY-HIDE GELATIN Co.,Ltd. Address before: 200436, Shanghai, Baoshan District, Shanghai Road, No. 1888, Wen Sheng building, 1 floor Patentee before: SHANGHAI SHINES PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: No.2888, Zhonghua West Road, hi tech Zone, Heze City, Shandong Province 274000 Patentee after: Shandong Guojiutang Pharmaceutical Group Co.,Ltd. Address before: No.2888, Zhonghua West Road, hi tech Zone, Heze City, Shandong Province 274000 Patentee before: GUOJIUTANG SHANDONG DONKEY-HIDE GELATIN CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |